CN101342239B - Pure natural medicament for treating AIDS - Google Patents
Pure natural medicament for treating AIDS Download PDFInfo
- Publication number
- CN101342239B CN101342239B CN2008102122563A CN200810212256A CN101342239B CN 101342239 B CN101342239 B CN 101342239B CN 2008102122563 A CN2008102122563 A CN 2008102122563A CN 200810212256 A CN200810212256 A CN 200810212256A CN 101342239 B CN101342239 B CN 101342239B
- Authority
- CN
- China
- Prior art keywords
- percent
- powder
- hiv
- pure natural
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 208000030507 AIDS Diseases 0.000 title claims description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 241001655769 Androsace Species 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims abstract description 7
- 241001465754 Metazoa Species 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 18
- 238000005303 weighing Methods 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 9
- 241000965254 Apostichopus japonicus Species 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 241000271915 Hydrophis Species 0.000 claims description 3
- 241000237636 Pheretima Species 0.000 claims description 3
- 241000195474 Sargassum Species 0.000 claims description 3
- 241000522620 Scorpio Species 0.000 claims description 3
- 206010047700 Vomiting Diseases 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000008673 vomiting Effects 0.000 claims description 3
- 239000010231 banlangen Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000009490 scorpio Substances 0.000 claims description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract description 7
- 230000036737 immune function Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 206010061598 Immunodeficiency Diseases 0.000 abstract description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract description 2
- 241000133430 Tinospora Species 0.000 abstract description 2
- 210000000987 immune system Anatomy 0.000 abstract description 2
- 230000007813 immunodeficiency Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000251511 Holothuroidea Species 0.000 abstract 1
- 241000271899 Hydrophis cyanocinctus Species 0.000 abstract 1
- 241000334154 Isatis tinctoria Species 0.000 abstract 1
- 241000245050 Menispermum Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 7
- 230000000840 anti-viral effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 241000700605 Viruses Species 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
- 229960002555 zidovudine Drugs 0.000 description 2
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000501098 Sargentodoxa Species 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a pure natural medicine remedying aids, which is a complex preparation prepared by extracting the effective active components of animal medicinal material and plant medicinal material. The components are as follows by weight percentage: 10 percent of hydrophis cyanocinctus, 10 percent of scorpion, 10 percent of earthworm, 5 percent of sea cucumber, 10 percent of seaweed, 10 percent of ginseng, 8 percent of angelica, 7 percent of honeysuckle, 5 percent of Androsace umbellate, 5 percent of sargentgloryvine stem, 5 percent of arrowshaped tinospora root, 5 percent of dandelion, 5 percent of asiatic moonseed rhizome and the rest of isatis indigotica fort.The invention takes the blood physic as the guidance, which can inhibit the copy of HIV and reconstruct immune system in addition to correcting immunodeficiency and renewing immune function. Aiming at that the cells of the parasitifer is infected by HIV; the invention can reduce the HIV RNA greatly. After drug withdrawal, the HIV RNA does not rebound, which makes the aids patients get well completely.
Description
Technical field
The present invention relates to the pure natural medical of a kind of HIV/AIDS of treatment, relate to a kind of immunologic function of recovering specifically, have the natural medicinal formulations that anti-HIV effect can be treated AIDS (AIDS).
Background technology
AIDS infects rapidly, the state of an illness is dangerous, mortality rate is high, wreaks havoc the whole world, seizes people's up to ten thousand life every day, has become 21 century human catastrophe sexually transmitted disease.Treatment AIDS does not still have safe and effective medicine at present.Ucleosides that popularize to use in the whole world and non-nucleoside 20 surplus chemical medicine of kind of antiviral or HAART (HAART); Only HIV replicative enzyme (HIV: reverse transcriptase, protease) there is certain inhibitory action; But to not had effect by the HIV infection cell; Even the HIV carrying capacity descends, but very easily bounce-back, and its toxicity is too big and drug resistance.So unsatisfactory curative effect.Because toxicity is big, is only limited to patients with terminal and uses and add and cost an arm and a leg that the patient is difficult to accept.Therefore demand developing a kind of new antiviral pure natural medical of the immunologic function of recovery that has urgently, the present invention just provides a kind of like this treatment AIDS pure natural medical safely and effectively.
Summary of the invention
The objective of the invention is to, through a kind of antiviral pure natural medical of the immunologic function of recovery that has is provided, be guidance with " Zhengxue medical science "; Extract the pure natural medical that marine organisms and multiple medical material effective active components are formed, can suppress HIV effectively and duplicate, can rebuild immune system again; Correct immunodeficiency, recover immunologic function, effectively be directed against the host by the HIV infection cell; Virus load is descended significantly, and virus load does not rebound after the drug withdrawal.And can eliminate opportunistic infection and complication thereof, recover body function comprehensively and make patient's rehabilitation.Have no side effect.
The present invention adopts following technological means to realize:
A kind of pure natural medical of treating AIDS is through extracting the compound formulation that multiple animal and plant medical material effective active components is formed; The percentage by weight that its prescription is formed is following:
Hydrophis cyanocinceus 10%, Scorpio 10%, Pheretima 10%, Stichopus japonicus 5%, Sargassum 10%, Radix Ginseng 10%, Radix Angelicae Sinensis 8%, Flos Lonicerae 7%, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 5%, Caulis Sargentodoxae 5%, Radix Tinosporae 5%, Herba Taraxaci 5%, Rhizoma Menispermi 5%, all the other are Radix Isatidis.
A kind of method for preparing of above-mentioned pure natural medical; All the other clean, cut into slices, smash by the prescription weighing plant amedica except that Radix Ginseng, add 8 times of watery vomiting stream percolation, filter, be concentrated into density 1.25; It is ethanol 60% that the injection Alcohol-settling tank adds 95% ethanol extremely rare; Static 24 hours, extract clear liquid and reclaim ethanol, get the fluid extract concentrate drying and get powder I;
All the other press square weighing extraction scheme to all animals medicine except that Stichopus japonicus: press the weighing of filling a prescription and pulverize, put into countercurrent extractor and add 8 times of 60% ethanol liquid countercurrent extraction, recovery ethanol gets fluid extract, concentrated, the dry powder II of getting; Radix Ginseng, Stichopus japonicus by square weighing, oven dry, pulverizing, are crossed 100 mesh sieves and become fine powder subsequent use, get powder III; Above-mentioned powder I, II, III mixed pulverize, allotment, stir, granulate, dry, detect, fill; Unit loading amount after making is 0.3g.
Described medicine is hard capsule or granule or tablet or pill or powder.
The present invention is a kind of to have the antiviral pure natural medical of the immune function and treating HIV/AIDS of recovery, compared with prior art, has following remarkable advantages and beneficial effect:
Behind the pharmacological testing of accomplishing by the high-tech authority's of China the Chinese Academy of Medical Sciences, Military Medical Science Institute, Chinese department of Chinese medicine institute etc., draw following effect data:
1, HIV-1 suppression ratio is reached 87.22% (AZT HAART principal agent zidovudine, suppression ratio 80%), dilutes 7700 times, still have inhibitory action:
2, HIV-1IIIB strain, 3DC persister, clinical separation strain are all had remarkable inhibitory action, therapeutic index is equal>455.4～7787.5;
3, HIV-1 intergrase there is inhibitory action (filling up world's blank);
4 and the recovery immunologic function arranged, effect such as antiviral, infection, anticancer, antiinflammatory, analgesia.Have no side effect.
The specific embodiment
Below in conjunction with specific embodiment with the explanation the present invention:
1, all the other press the prescription weighing to plant amedica except that Radix Ginseng, clean, cut into slices, smash, and add 8 times of watery vomiting stream percolation, filter, be concentrated into density 1.25, and it is ethanol 60% that the injection Alcohol-settling tank adds 95% ethanol extremely rare, static 24 hours, extracts clear liquid and reclaims ethanol.Get the fluid extract concentrate drying and get powder I.
2, all the other extract scheme by square weighing to animal drugs except that Solenognathus:
Press the weighing of filling a prescription and pulverize, put into countercurrent extractor and add 8 times of 60% ethanol liquid countercurrent extraction, reclaim ethanol, get fluid extract, concentrated, the dry powder II of getting.
3, Radix Ginseng, Stichopus japonicus are pressed square weighing, oven dry, pulverizing, cross 100 mesh sieves and become fine powder subsequent use, get powder III;
With above-mentioned that powder I, II, III mix pulverizing, allotment, stirring, granulation, drying, detection, filled capsules.
The capsule loading amount is the 0.3g/ grain, usage and dosage: oral, and the adult, 4-5/inferior, one is three times, children's is cut down according to the circumstance.
After above method configuration, the content of medicine (quality, umber) is specially:
Hydrophis cyanocinceus 100 gram Scorpios 100 gram Pheretimas 100 gram Stichopus japonicuss 50 gram Sargassums 100 gram Radix Ginsengs 100 gram Radix Angelicae Sinensis 80 gram Flos Loniceraes 70 gram Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 50 gram Caulis Sargentodoxaes 50 gram Radix Tinosporaes 50 gram Herba Taraxacis 50 gram Rhizoma Menispermis 50 gram Radix Isatidiss 50 grams.
Described medicine is hard capsule or granule or tablet or pill or powder.
With the medicine after the above configuration, after clinical experiment, obtained obvious effects.
In 148 examples that clinical observation detects, eliminated clinical symptoms in 1-2 months no matter early, middle and late phase patient takes medicine, 6-9 months immune indexes of taking medicine reach normal or approaching normal, and the HIV carrying capacity descends significantly or reaches the level of can not check.Obvious effective rate 85.5%, total effective rate 98%.
The present inventor comes in 10 examples that detected in 7 years by a definite date in AIDS village, Henan, 38 months virus loads of 2 routine drug withdrawals occur and can not check; 32 months virus of all the other patient's drug withdrawals does not rebound; The HIV carrying capacity is controlled in extremely low-level, and immune indexes maintains normal or near normal level, and is healthy.Can prejudge and take the present invention and can not fall ill all the life.
This project is classified country " 15 " key scientific and technological projects as, organizes clinical evaluation research by State Administration of Traditional Chinese Medicine.These clinical 73 example tests, with the HAART parallel control, the result shows: the present invention can reduce the HIV carrying capacity, can eliminate symptom, weight increase, raising quality of life, is excellent than HAART.
Describe with several model cases below:
Beam so-and-so, the man, 3 years old, breast milk was propagated; ADIS end-stage patients, low grade fever, diarrhoea, herpes simplex, anorexia, dysplasia before the treatment, CD4277cells/ul, HIV carrying capacity 240000cp/ml; 1 month above-mentioned symptom of taking medicine is eliminated, 5 months CD41847cells/ul that take medicine, HIV carrying capacity < LDL, 3 years 2 months seven times checks of drug withdrawal immediately CD4>1282-2738cells/ul; The HIV carrying capacity all can not check, and HIV antibody is turned out cloudy, observe 7 years healthy.
Korea Spro so-and-so, man, 32 years old, peasant, the infection of donating blood with compensation; ADIS patient in mid-term, weak before the treatment, become thin, diarrhoea, low grade fever, CD4cell/ul, HIV carrying capacity 3200cp/ml; Take medicine and eliminated symptom in 1 month, the check CD4210-387cells/ul that takes medicine 42 months 7 times, HIV carrying capacity 11000-LDL, drug withdrawal detects the HIV carrying capacity twice after 32,35 months and all can not check; So far 7 years healthy, goes out to do manual work the logrolling in the forest farm, Mount Taishan, heavy physical labour.
Zhang, woman, 39 years old, peasant, the infection of donating blood with compensation, phase approaching one's end; The patient that is critically ill is unable to leave the bed, and mouthful does not take food five days, and syncope is hung by a hair, and its husband puts on shroud for her; Get funerary objects ready, the relative of the married woman's parents' home funeral affairs of having visited to handle, use the present invention's treatment after, take a turn for the better everyday, serve on 15 days; The activity of getting up serve on three months, work orthobiosis, and the back is because of after the drug withdrawal of believing in a religion 1 year 2 months, disease relapse death.
What should explain at last is: above embodiment only in order to the explanation the present invention and and unrestricted technical scheme described in the invention; Therefore, although this description has been carried out detailed explanation to the present invention with reference to each above-mentioned embodiment,, those of ordinary skill in the art should be appreciated that still and can make amendment or be equal to replacement the present invention; And all do not break away from the technical scheme and the improvement thereof of the spirit and the scope of invention, and it all should be encompassed in the middle of the claim scope of the present invention.
Claims (3)
1. a pure natural medical of treating AIDS is characterized in that: through extracting the compound formulation that multiple animal and plant medical material effective active components is formed; The percentage by weight of aforementioned animal and plant medical material is:
Hydrophis cyanocinceus 10%, Scorpio 10%, Pheretima 10%, Stichopus japonicus 5%, Sargassum 10%, Radix Ginseng 10%, Radix Angelicae Sinensis 8%, Flos Lonicerae 7%, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 5%, Caulis Sargentodoxae 5%, Radix Tinosporae 5%, Herba Taraxaci 5%, Rhizoma Menispermi 5%, all the other are Radix Isatidis.
2. a kind of pure natural medical of treating AIDS according to claim 1 is characterized in that: described medicine is hard capsule, granule, tablet, pill or powder.
3. method for preparing of pure natural medical according to claim 1; It is characterized in that: all the other clean, cut into slices, smash by the prescription weighing plant amedica except that Radix Ginseng, add 8 times of watery vomiting stream percolation, filter, be concentrated into density 1.25; It is ethanol 60% that the injection Alcohol-settling tank adds 95% ethanol extremely rare; Left standstill 24 hours, and extracted clear liquid and reclaim ethanol, get the fluid extract concentrate drying and get powder I;
All the other press square weighing, the extraction scheme to animal drugs except that Stichopus japonicus:
Press the weighing of filling a prescription and pulverize, put into countercurrent extractor and add 8 times of 60% ethanol liquid countercurrent extraction, reclaim ethanol, get fluid extract, concentrated, the dry powder II of getting;
Radix Ginseng, Stichopus japonicus by square weighing, oven dry, pulverizing, are crossed 100 mesh sieves and become fine powder subsequent use, get powder III;
Above-mentioned powder I, II, III mixed pulverize, allotment, stir, granulate, dry, detect, fill; Unit loading amount after making is 0.3g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102122563A CN101342239B (en) | 2008-09-08 | 2008-09-08 | Pure natural medicament for treating AIDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102122563A CN101342239B (en) | 2008-09-08 | 2008-09-08 | Pure natural medicament for treating AIDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101342239A CN101342239A (en) | 2009-01-14 |
| CN101342239B true CN101342239B (en) | 2012-05-23 |
Family
ID=40244430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102122563A Expired - Fee Related CN101342239B (en) | 2008-09-08 | 2008-09-08 | Pure natural medicament for treating AIDS |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101342239B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569408B (en) * | 2009-04-23 | 2012-12-26 | 湛江市贤博科技有限公司 | Pure nature food for improving human health |
| CN101569407B (en) * | 2009-04-23 | 2013-10-16 | 湛江市贤博科技有限公司 | Pure nature food for improving human body function |
| WO2015130251A1 (en) | 2014-02-26 | 2015-09-03 | Bülbül Şevger | Manufacturing method of a natural composition formed of the offal meats for the recovery of aids illness |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1212870A (en) * | 1997-09-30 | 1999-04-07 | 刘建安 | Oral liquid for anti-AIDS and venereal disease |
| CN1839987A (en) * | 2006-01-19 | 2006-10-04 | 张连波 | AIDS resistant medicine- porcher capsule and production technology |
-
2008
- 2008-09-08 CN CN2008102122563A patent/CN101342239B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1212870A (en) * | 1997-09-30 | 1999-04-07 | 刘建安 | Oral liquid for anti-AIDS and venereal disease |
| CN1839987A (en) * | 2006-01-19 | 2006-10-04 | 张连波 | AIDS resistant medicine- porcher capsule and production technology |
Non-Patent Citations (2)
| Title |
|---|
| 李崇忠等.中医药治疗艾滋病理论的建立与临证应用.《实用中医内科杂志》.2002,第16卷(第02期), * |
| 黄建设等.海洋天然产物及其生理活性的研究进展.《海洋通报》.2001,第20卷(第04期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101342239A (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109674958A (en) | A kind of Chinese medicine composition and its preparation method and application with anti-trioxypurine | |
| CN101773527B (en) | Pinecone extractive of Yunnan Pinus and preparation method and medicinal application thereof | |
| CN103446525B (en) | Treat dermopathic Chinese medicine composition and its preparation method and application | |
| CN101342239B (en) | Pure natural medicament for treating AIDS | |
| CN103585561B (en) | A kind of Chinese medicine composition for the treatment of gout | |
| CN101683423B (en) | Application of Chinese medicine composition in preparation of medicament for treating chicken pox | |
| CN102908443B (en) | Medicinal composition for therapy or adjuvant therapy of aids, preparation method of medicinal composition and application of medicinal composition | |
| CN103356728B (en) | Pharmaceutical composition, preparation method thereof, preparations thereof and application thereof | |
| CN102895399A (en) | Natural drug for treating human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) | |
| WO1993013787A1 (en) | Immunopotentiating agent | |
| CN101073625B (en) | Medicinal composition with anti-infective and anti-inflammatory functions | |
| CN105497126A (en) | Chinese medicinal composition for treating piglet epidemic diarrhea | |
| CN101559114A (en) | Application of traditional Chinese medicine composition in preparing antihypoxic | |
| CN101224200B (en) | Novel anti-systematic erythema lupus medicine | |
| CN101926948A (en) | Uigur medicament for treating AIDS and preparation method thereof | |
| CN103505500B (en) | A kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof | |
| CN103191386B (en) | Medicament for treating chronic hepatitis B | |
| CN101537150B (en) | Medicine for treating pulmonary tuberculosis | |
| CN101607009B (en) | Pharmaceutical composition for treating cold | |
| CN101543615A (en) | Method for preparing Chinese medicinal combination for treating gall-stone | |
| CN102058668A (en) | Traditional Chinese medicinal preparation for treating primary thrombocytopenia | |
| CN100443093C (en) | AIDS treating medicine | |
| CN101152262A (en) | Anti-gout novel medical preparation | |
| CN103585500B (en) | A kind of medicament for the treatment of diarrhoea | |
| CN104225014B (en) | A kind of Tibetan medicine for the treatment of diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANGJIANG XIANBO SCIENCE + TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: MO YIXIAN Effective date: 20110131 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 524044 NO.91 (ZHANJIANG XIANBO TECHNOLOGY CO., LTD.), NORTH OF HAIBIN AVENUE, ZHANJIANG CITY, GUANGDONG PROVINCE TO: 524044 ROOM 806, NO.61, SOUTH OF HAIBIN AVENUE, DEVELOPMENT AREA, ZHANJIANG CITY, GUANGDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110131 Address after: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Applicant after: Zhanjiang Xianbo Technology Co., Ltd. Address before: 524044, No. 91, Haibin Avenue, Zhanjiang City, Guangdong province (Zhanjiang Yin Bo Technology Co., Ltd.) Applicant before: Mo Yixian |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200420 Address after: Room 1115, building 1, Evergrande oasis garden, No. 12, Haiwan South Road, Potou District, Zhanjiang City, Guangdong Province Patentee after: Zhanjiang Tiantai Pharmaceutical Technology Co., Ltd Address before: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Patentee before: ZHANJIANG XIANBO TECHNOLOGY Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20200908 |